128 related articles for article (PubMed ID: 35502635)
1. Myeloid differentiation factor-2 activates monocytes in patients with dilated cardiomyopathy.
Feldtmann R; Kümmel A; Chamling B; Strohbach A; Lehnert K; Gross S; Loerzer L; Riad A; Lindner D; Westermann D; Fielitz J; Dörr M; Felix SB
Immunology; 2022 Sep; 167(1):40-53. PubMed ID: 35502635
[TBL] [Abstract][Full Text] [Related]
2. Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD-2/MyD88-mediated NF-κB signaling.
Ye K; Chen QW; Sun YF; Lin JA; Xu JH
J Cell Biochem; 2018 Feb; 119(2):1922-1930. PubMed ID: 28815730
[TBL] [Abstract][Full Text] [Related]
3. Ergosta-7, 9 (11), 22-trien-3β-ol Interferes with LPS Docking to LBP, CD14, and TLR4/MD-2 Co-Receptors to Attenuate the NF-κB Inflammatory Pathway
Hsieh WT; Hsu MH; Lin WJ; Xiao YC; Lyu PC; Liu YC; Lin WY; Kuo YH; Chung JG
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204506
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effect of procyanidin B1 on LPS-treated THP1 cells via interaction with the TLR4-MD-2 heterodimer and p38 MAPK and NF-κB signaling.
Xing J; Li R; Li N; Zhang J; Li Y; Gong P; Gao D; Liu H; Zhang Y
Mol Cell Biochem; 2015 Sep; 407(1-2):89-95. PubMed ID: 26037075
[TBL] [Abstract][Full Text] [Related]
5. Anti-β2GPI/β2GPI stimulates activation of THP-1 cells through TLR4/MD-2/MyD88 and NF-κB signaling pathways.
Zhou H; Sheng L; Wang H; Xie H; Mu Y; Wang T; Yan J
Thromb Res; 2013; 132(6):742-9. PubMed ID: 24157085
[TBL] [Abstract][Full Text] [Related]
6. Anti-Inflammatory Activity of Adenosine 5'-Trisphosphate in Lipopolysaccharide-Stimulated Human Umbilical Vein Endothelial Cells Through Negative Regulation of Toll-Like Receptor MyD88 Signaling.
Luo X; Xiao B; Xiao Z
DNA Cell Biol; 2019 Dec; 38(12):1557-1563. PubMed ID: 31580158
[TBL] [Abstract][Full Text] [Related]
7. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A3 binds MD-2 to activate p38 and NF-κB pathways in a MyD88-dependent manner.
Deguchi A; Tomita T; Omori T; Komatsu A; Ohto U; Takahashi S; Tanimura N; Akashi-Takamura S; Miyake K; Maru Y
J Immunol; 2013 Aug; 191(4):1856-64. PubMed ID: 23858030
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.
Ben Haij N; Planès R; Leghmari K; Serrero M; Delobel P; Izopet J; BenMohamed L; Bahraoui E
PLoS One; 2015; 10(6):e0129425. PubMed ID: 26090662
[TBL] [Abstract][Full Text] [Related]
10. Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.
Liu H; Zhang G; Huang J; Ma S; Mi K; Cheng J; Zhu Y; Zha X; Huang W
J Transl Med; 2016 Apr; 14(1):104. PubMed ID: 27118139
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
Zhao W; Ma G; Chen X
Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids from Radix Tetrastigmae inhibit TLR4/MD-2 mediated JNK and NF-κB pathway with anti-inflammatory properties.
Liu D; Cao G; Han L; Ye Y; SiMa Y; Ge W
Cytokine; 2016 Aug; 84():29-36. PubMed ID: 27235587
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 regulates LPS-induced TLR4/MD-2 pathway activation and inflammation in alveolar macrophages.
Ren W; Wang Z; Hua F; Zhu L
Inflammation; 2015 Feb; 38(1):384-93. PubMed ID: 25342286
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of myeloid differentiation protein 2 attenuates renal ischemia/reperfusion-induced oxidative stress and inflammation via suppressing TLR4/TRAF6/NF-kB pathway.
Hu X; Ding C; Ding X; Fan P; Zheng J; Xiang H; Li X; Qiao Y; Xue W; Li Y
Life Sci; 2020 Sep; 256():117864. PubMed ID: 32474021
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
[TBL] [Abstract][Full Text] [Related]
16. Exogenous MD-2 confers lipopolysaccharide responsiveness to human corneal epithelial cells with intracellular expression of TLR4 and CD14.
Lang LL; Wang L; Liu L
Inflammation; 2011 Oct; 34(5):371-8. PubMed ID: 20700758
[TBL] [Abstract][Full Text] [Related]
17. Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4.
Pizzuto M; Lonez C; Baroja-Mazo A; Martínez-Banaclocha H; Tourlomousis P; Gangloff M; Pelegrin P; Ruysschaert JM; Gay NJ; Bryant CE
Cell Mol Life Sci; 2019 Sep; 76(18):3667-3678. PubMed ID: 31062071
[TBL] [Abstract][Full Text] [Related]
18. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance.
Medvedev AE; Piao W; Shoenfelt J; Rhee SH; Chen H; Basu S; Wahl LM; Fenton MJ; Vogel SN
J Biol Chem; 2007 Jun; 282(22):16042-53. PubMed ID: 17392283
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel ameliorates lipopolysaccharide-induced kidney injury by binding myeloid differentiation protein-2 to block Toll-like receptor 4-mediated nuclear factor-κB activation and cytokine production.
Zhang D; Li Y; Liu Y; Xiang X; Dong Z
J Pharmacol Exp Ther; 2013 Apr; 345(1):69-75. PubMed ID: 23318472
[TBL] [Abstract][Full Text] [Related]
20. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
